S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged

Intellia Therapeutics (NTLA) Insider Trading & Ownership

$21.57
+0.25 (+1.17%)
(As of 04/19/2024 08:51 PM ET)

Intellia Therapeutics (NASDAQ:NTLA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.00%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$1.37 M
Get NTLA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Intellia Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NTLA Insider Buying and Selling by Quarter

Intellia Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/4/2024James BastaEVPSell2,297$32.99$75,778.03  
1/8/2024Laura Sepp-LorenzinoEVPSell2,275$28.87$65,679.25  
1/3/2024David LebwohlEVPSell5,843$29.46$172,134.78  
1/3/2024Glenn GoddardCFOSell5,365$29.46$158,052.90  
1/3/2024John M LeonardCEOSell19,223$29.46$566,309.58  
10/31/2023Muna BhanjiDirectorSell265$23.90$6,333.50  
8/25/2023Thomas R. CarperU.S. Congress Member (D-DE)Sell$38.25$1,001 - $15,000
7/31/2023Muna BhanjiDirectorSell265$42.33$11,217.45  
7/6/2023Muna BhanjiDirectorSell1,867$39.30$73,373.10  
7/3/2023Eliana ClarkEVPSell360$40.51$14,583.60  
6/20/2023Eliana ClarkEVPSell5,000$45.00$225,000.00  
(Data available from 1/1/2013 forward)

NTLA Insider Trading Activity - Frequently Asked Questions

Who is on Intellia Therapeutics's Insider Roster?

The list of insiders at Intellia Therapeutics includes David Lebwohl, Eliana Clark, Glenn Goddard, James Basta, Jean Francois Formela, John F Crowley, John M Leonard, Laura Sepp-Lorenzino, and Muna Bhanji. Learn more on insiders at NTLA.

What percentage of Intellia Therapeutics stock is owned by insiders?

3.00% of Intellia Therapeutics stock is owned by insiders. Learn more on NTLA's insider holdings.

Which Intellia Therapeutics insiders have been selling company stock?

The following insiders have sold NTLA shares in the last 24 months: David Lebwohl ($172,134.78), Eliana Clark ($239,583.60), Glenn Goddard ($248,361.57), James Basta ($75,778.03), John M Leonard ($814,611.91), Laura Sepp-Lorenzino ($159,001.93), and Muna Bhanji ($90,924.05).

How much insider selling is happening at Intellia Therapeutics?

Insiders have sold a total of 54,368 Intellia Therapeutics shares in the last 24 months for a total of $1,800,395.87 sold.

Which members of congress are trading Intellia Therapeutics?

Thomas R. Carper (D-DE) has bought shares of Intellia Therapeutics in the last year totaling $8,000. Thomas R. Carper (D-DE) has sold shares totaling $8,000.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:NTLA) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners